Medical Director MD, Clinical Development, Endocrinology
Neurocrine Biosciences
August 30, 2026
Remote friendly (San Diego, CA)
United States
Clinical Research and Development
Medical Director will advance clinical programs by partnering with Clinical Operations, Regulatory Affairs, Drug Safety, Biometrics, Translational Medicine, Research, and Medical Affairs colleagues, providing scientific and medical expertise across study design, clinical execution, safety evaluation, biomarker strategies, and data interpretation for endocrine and metabolic disorders.
Your Contributions (include, But Are Not Limited To)
- Provide medical leadership for Phase 1β3 clinical studies within the endocrinology portfolio.
- Develop and implement clinical study protocols with multidisciplinary development teams.
- Serve as Sponsor medical monitor; maintain relationships with investigators, study sites, and external experts.
- Review and assess clinical safety data, including adverse events and emerging safety signals (with Drug Safety).
- Partner with Clinical Operations to ensure GCP compliance and adherence to regulations and company procedures.
- Analyze, interpret, and communicate clinical results to internal and external scientific audiences.
- Contribute to preparation/review of clinical study reports, regulatory documents, presentations, and publications.
- Support translational and biomarker strategy development and implementation.
- Collaborate with Medical Affairs and external experts to communicate clinical findings.
- Participate in evaluation of new development opportunities and clinical strategy discussions.
- Assist with study planning, resource forecasting, and engagement of external consultants/CROs.
Requirements
- MD or DO with accredited residency training and board certification in relevant specialty AND 2+ years clinical R&D experience (Phase 1-4) in pharma/biotech or clinical research/academic setting.
- Strong understanding of clinical drug development, study design, and trial execution.
- Knowledge of GCP, regulatory requirements, and clinical development processes.
- Experience interpreting clinical/safety data and communicating findings.
- Understanding of translational medicine, biomarker development, and clinical pharmacology.
- Strong analytical/problem-solving and communication/collaboration skills.
- Ability to work in a matrix environment and manage multiple priorities.
- Proven success collaborating with CROs, investigators, consultants, and cross-functional teams.
Preferred Qualifications
- Board certification in Endocrinology.
- Endocrine/metabolic clinical development experience.
- Medical monitor/study physician experience.
- Early-/late-stage clinical development experience.
- Familiarity with regulatory interactions and clinical submission activities.
- Interest in advancing innovative endocrine therapies.
Compensation/Benefits (as stated)
- Annual base salary: $254,600.00β$347,000.00; annual bonus target 35% of earned base; equity long-term incentive eligibility.
- Retirement savings plan (with company match), paid vacation/holidays/personal days, paid caregiver/parental and medical leave, and health benefits (medical, prescription drug, dental, vision).
Your Contributions (include, But Are Not Limited To)
- Provide medical leadership for Phase 1β3 clinical studies within the endocrinology portfolio.
- Develop and implement clinical study protocols with multidisciplinary development teams.
- Serve as Sponsor medical monitor; maintain relationships with investigators, study sites, and external experts.
- Review and assess clinical safety data, including adverse events and emerging safety signals (with Drug Safety).
- Partner with Clinical Operations to ensure GCP compliance and adherence to regulations and company procedures.
- Analyze, interpret, and communicate clinical results to internal and external scientific audiences.
- Contribute to preparation/review of clinical study reports, regulatory documents, presentations, and publications.
- Support translational and biomarker strategy development and implementation.
- Collaborate with Medical Affairs and external experts to communicate clinical findings.
- Participate in evaluation of new development opportunities and clinical strategy discussions.
- Assist with study planning, resource forecasting, and engagement of external consultants/CROs.
Requirements
- MD or DO with accredited residency training and board certification in relevant specialty AND 2+ years clinical R&D experience (Phase 1-4) in pharma/biotech or clinical research/academic setting.
- Strong understanding of clinical drug development, study design, and trial execution.
- Knowledge of GCP, regulatory requirements, and clinical development processes.
- Experience interpreting clinical/safety data and communicating findings.
- Understanding of translational medicine, biomarker development, and clinical pharmacology.
- Strong analytical/problem-solving and communication/collaboration skills.
- Ability to work in a matrix environment and manage multiple priorities.
- Proven success collaborating with CROs, investigators, consultants, and cross-functional teams.
Preferred Qualifications
- Board certification in Endocrinology.
- Endocrine/metabolic clinical development experience.
- Medical monitor/study physician experience.
- Early-/late-stage clinical development experience.
- Familiarity with regulatory interactions and clinical submission activities.
- Interest in advancing innovative endocrine therapies.
Compensation/Benefits (as stated)
- Annual base salary: $254,600.00β$347,000.00; annual bonus target 35% of earned base; equity long-term incentive eligibility.
- Retirement savings plan (with company match), paid vacation/holidays/personal days, paid caregiver/parental and medical leave, and health benefits (medical, prescription drug, dental, vision).